← All companies

ATXI

Avenue Therapeutics, Inc.

ATXI OTC Pharmaceutical Preparations EDGAR ↗

$0.37

-0.02 -4.26%

Key statistics

from XBRL data in SEC filings

Market cap

$1.22M

Revenue (TTM)

$1.40M

Net income (TTM)

-$1.75M

EPS (TTM)

$-0.93

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$2.42M

Total assets

$2.47M

Gross margin

—

52-week range

$0.15 – $0.97

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Other events Feb 23, 2026 8-K Shareholder vote results Dec 31, 2025 8-K Item 5.08; Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Director or officer change; Other events Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Delisting notice or listing-rule failure Mar 17, 2025 8-K Other events Mar 7, 2025 8-K Delisting notice or listing-rule failure Nov 29, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Director or officer change; Shareholder vote results Jun 26, 2024 8-K Other events May 23, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 8-K Entered a material agreement May 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events May 1, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Apr 26, 2024 8-K Delisting notice or listing-rule failure Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024 8-K Results of operations (earnings release) Mar 18, 2024 8-K Other events Mar 15, 2024 8-K Shareholder vote results Mar 8, 2024 8-K Amended charter or bylaws Feb 23, 2024 8-K Shareholder vote results Jan 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events Jan 8, 2024 8-K Delisting notice or listing-rule failure Nov 24, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Entered a material agreement; Other events Nov 2, 2023 8-K Delisting notice or listing-rule failure Sep 28, 2023 8-K Other events Sep 27, 2023